I think the current discussion is an important one that may well yield valuable information and put to rest lingering questions about Coumadin and warfarin. I don't think the critical issue is whether Coumadin or warfarin cause petechiae. I've had petechiae many times and I don't take anticoagulants. My former doctor even joked about me getting into Al's blood thinners. Petechiae is also very common among HIV sufferers. I don't have HIV. Petechiae is often caused by low platlet counts, which could be caused by many things, including anticoagulants--branded or generic. People who switch from branded drugs to generic often get rashes of one sort or another, according to my dermotologist. While branded drugs and generic drugs may have bioequivalence, they are often times different in the fillers that they contain. It is the filler that can cause problems, including rashes. But this discussion isn't about rashes. It is about the equivalence of Coumadin and warfarin, and more specifically about switching from Coumadin to warfarin.
I would like to suggest that those who are interested locate information and articles, including research studies, case studies, FDA materials, documents from experts, and any other information available and share it here. I believe that our resident expert, Al Lodwick, would help us sort through what is available so that we might come to a better understanding of the issues involved and the various elements that go into determining bioequlvalence and clinical equivalence of Coumadin and warfarin. I searched Medscape, Medline, and authors, and titles, and the Annals of Pharmacotherapy. There seem to be few studies avaliable. Perhaps that is because there doesn't seem to be an interest in the topic. As James McCormack, Pharm.D. said,..we all wish that the pharmaceutical companies would sponsor more well=designed clinical comparative trials (not just to address generic-brand equivalence) in an attempt to definitively address IMPORTANT PRODUCT QUESTIONS.....I think it's about time we got on with doing research in more important areas than the generic versus brand name issue....(Journal of Informed Pharmacotherapy, Editorial, "The warfarIN debate is weaRing thin," 2001.
http://wwwinformedpharmacotherapy.com/Issue6/Editorial/McCormack editorial.htm
I also found the following:
Weibert RT, Yeager BF, Wittkowski AK, et al. The Annals of Pharmacotherapy. 200, 34(9) 981-988. "A Randomized Crossover Comparison of Warfarin Products in the Treatment of Chronic Arterial Fibrilation."
http://www.medscape.com/viewarticle/404254_2
Expistaxis Associated with Elevation of INR in a Patient Switched to Generic Warfarin, Pharmacotherapy 20(2) 240-243, 2000.
http://medscape.com/viewarticle/409516_print
E-Drug: U.S. FDA says generic drugs as good as brand names.
http://www.essentialdrugs.ord/edrug/hma/e-drug.199802/msg00006.php
Generic Substitutions: Issues for Problematic Drugs, South Med Journal 94(1) 16-21, 2001.
http://www.medscape.com/viewarticle/410695_print
****Personal note: This article includes warfarin and other drugs. You can read about Albuterol, the generic for Ventolin inhaler. This is the one that landed me in the emergency room!!
I've included 5 references as a start. I did find 7 more. If people are indeed interested and want to follow-up on this, I think we can gain more information on a topic that has been vexing me and concerning some others for a long time. It really isn't as simple as it seems. Information and understanding makes us all winners.
Blanche